Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Charpentier

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal Francais D'Ophtalmologie|January 1, 1994
[Conjunctival epidermoid carcinoma and human immunodeficiency virus]P Denis, D Charpentier, M Roudier, et al.
Molecular Pharmaceutics|December 5, 2022
Multicomponent Chiral Quantification with Ultraviolet Circular Dichroism Spectroscopy: Ternary and Quaternary Phase Diagrams of LevetiracetamMaxime D Charpentier, Raghunath Venkatramanan, Céline Rougeot, et al.
Biochemistry|December 22, 2000
Low- and high-density lipoprotein metabolism in HepG2 cells expressing various levels of apolipoprotein ED Charpentier, C Tremblay, E Rassart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2006
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG)M E Trudeau, M Crump, D Charpentier, et al.
Angewandte Chemie (International Ed. in English)|July 7, 2021
Simultaneous Chiral Resolution of Two Racemic Compounds by Preferential Cocrystallization*Fuli Zhou, Oleksii Shemchuk, Maxime D Charpentier, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndromeC Roy, J P Adam, F Morin, et al.
Leukemia & Lymphoma|August 10, 1999
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomasP Goss, A K Stewart, F Couture, et al.
Crystal Growth & Design|September 13, 2022
Comparing and Quantifying the Efficiency of Cocrystal Screening Methods for PraziquantelMaxime D Charpentier, Jan-Joris Devogelaer, Arnoud Tijink, et al.
Crystal Growth & Design|July 19, 2021
Cocrystals of Praziquantel: Discovery by Network-Based Link PredictionJan-Joris Devogelaer, Maxime D Charpentier, Arnoud Tijink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2006
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115J A Maroun, K Belanger, L Seymour, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal Francais D'Ophtalmologie|January 1, 1994
[Conjunctival epidermoid carcinoma and human immunodeficiency virus]P Denis, D Charpentier, M Roudier, et al.
Molecular Pharmaceutics|December 5, 2022
Multicomponent Chiral Quantification with Ultraviolet Circular Dichroism Spectroscopy: Ternary and Quaternary Phase Diagrams of LevetiracetamMaxime D Charpentier, Raghunath Venkatramanan, Céline Rougeot, et al.
Biochemistry|December 22, 2000
Low- and high-density lipoprotein metabolism in HepG2 cells expressing various levels of apolipoprotein ED Charpentier, C Tremblay, E Rassart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2006
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG)M E Trudeau, M Crump, D Charpentier, et al.
Angewandte Chemie (International Ed. in English)|July 7, 2021
Simultaneous Chiral Resolution of Two Racemic Compounds by Preferential Cocrystallization*Fuli Zhou, Oleksii Shemchuk, Maxime D Charpentier, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndromeC Roy, J P Adam, F Morin, et al.
Leukemia & Lymphoma|August 10, 1999
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomasP Goss, A K Stewart, F Couture, et al.
Crystal Growth & Design|September 13, 2022
Comparing and Quantifying the Efficiency of Cocrystal Screening Methods for PraziquantelMaxime D Charpentier, Jan-Joris Devogelaer, Arnoud Tijink, et al.
Crystal Growth & Design|July 19, 2021
Cocrystals of Praziquantel: Discovery by Network-Based Link PredictionJan-Joris Devogelaer, Maxime D Charpentier, Arnoud Tijink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2006
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115J A Maroun, K Belanger, L Seymour, et al.
Pageof 3